Aquatic Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Aquatic Capital Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$118K	Buy	+6,805	New	+$93.3K	﹤0.01%	1073
2025 Q4	–	Sell	-87,588	Closed	-$877K	–	1381
2025 Q3	$877K	Buy	87,588 +40,209	+85%	+$361K	0.02%	715
2025 Q2	$383K	Buy	47,379 +42,533	+878%	+$321K	0.01%	886
2025 Q1	$40.6K	Sell	4,846 -52,764	-92%	-$440K	﹤0.01%	1150
2024 Q4	$456K	Buy	+57,610	New	+$483K	0.01%	738
2024 Q3	–	Sell	-17,100	Closed	-$109K	–	1130
2024 Q2	$109K	Sell	17,100 -54,800	-76%	-$348K	﹤0.01%	875
2024 Q1	$436K	Buy	+71,900	New	+$405K	0.01%	578
2022 Q4	–	Sell	-3,300	Closed	-$7K	–	1330
2022 Q3	$7K	Buy	3,300 +1,800	+120%	+$5.04K	﹤0.01%	1071
2022 Q2	$5K	Buy	+1,500	New	+$5.43K	﹤0.01%	1038

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Aquatic Capital Management's AMRX Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2026: 6,805 shares worth $118K. The stake represents ﹤0.01% of the portfolio and ranks #1073 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in AMRX as recently as Q3 2025.

Aquatic Capital Management first reported a position in AMRX in Q2 2022 and has held it in 9 quarters since. The position peaked at $877K in Q3 2025. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Aquatic Capital Management held 6,805 shares of Amneal Pharmaceuticals worth $118K as of Q2 2026.
Amneal Pharmaceuticals was a new Aquatic Capital Management position in Q2 2026.
Amneal Pharmaceuticals made up ﹤0.01% of Aquatic Capital Management's portfolio in Q2 2026, its #1073 holding.
Aquatic Capital Management first reported a position in Amneal Pharmaceuticals in Q2 2022 and has held it in 9 quarters since.
Aquatic Capital Management's Amneal Pharmaceuticals position peaked at $877K in Q3 2025.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.